CervoMed Inc. — Director's Dealing 2023

Aug 23, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CervoMed Inc. (CRVO)
CIK: 0001053691
Period of Report: 2023-08-16

Reporting Person: Poulton Jeffrey V. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$19.8100	2028-05-29	Common Stock (6906)		Direct
Stock Option (Right to Buy)	$26.0600	2029-12-16	Common Stock (3453)		Direct
Stock Option (Right to Buy)	$34.8400	2031-03-12	Common Stock (2302)		Direct
Stock Option (Right to Buy)	$19.4600	2032-03-10	Common Stock (2302)		Direct

Footnotes

F1: Shares of common stock of the corporation then known as EIP Pharma, Inc. ("EIP") were converted (after giving effect to the conversion of each share of EIP's preferred stock and EIP's convertible promissory notes into EIP's common stock) into shares of the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of March 30, 2023, by and among the EIP, Dawn Merger Sub, Inc. and the Issuer (formerly known as Diffusion Pharmaceuticals, Inc.) (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of EIP common stock was exchanged for 0.1151 shares of the Issuer's common stock, after giving effect to a reverse split of the Issuer's common stock of 1-for-1.5.

F2: Represents 6,906 stock options granted under the Issuer's 2018 Equity Incentive Plan (the "Plan"). The stock options vest in equal monthly installments over thirty-six (36) months thereafter.

F3: Represents 3,453 stock options granted under the Plan. Twenty-five percent (25%) of the stock options vest on the one-year anniversary of December 16, 2019 with the remaining options vesting in equal monthly installments over thirty-six (36) months thereafter.

F4: Represents 2,302 stock options granted under the Plan. Twenty-five percent (25%) of the stock options vest on the one-year anniversary of March 12, 2021 with the remaining options vesting in equal monthly installments over thirty-six (36) months thereafter.

F5: Represents 2,302 stock options granted under the Plan. Twenty-five percent (25%) of the stock options vest on the one-year anniversary of March 10, 2022 with the remaining options vesting in equal monthly installments over thirty-six (36) months thereafter.